2.26
Creative Medical Technology Holdings Inc stock is traded at $2.26, with a volume of 32,952.
It is up +5.74% in the last 24 hours and down -27.54% over the past month.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
See More
Previous Close:
$2.09
Open:
$2.1799
24h Volume:
32,952
Relative Volume:
0.34
Market Cap:
$5.57M
Revenue:
$102.80K
Net Income/Loss:
$-5.32M
P/E Ratio:
-0.5947
EPS:
-3.8
Net Cash Flow:
$-5.45M
1W Performance:
+0.91%
1M Performance:
-27.54%
6M Performance:
-1.34%
1Y Performance:
-3.49%
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CELZ
Creative Medical Technology Holdings Inc
|
2.16 | 5.39M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.59 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.66 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
871.72 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.94 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
202.62 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Will Creative Medical Technology Holdings Inc. stock see insider buyingTrade Performance Summary & Free High Return Stock Watch Alerts - Bollywood Helpline
Creative Medical Technology completes enrollment in FDA-cleared Adapt trial - marketscreener.com
Creative Medical completes enrollment in chronic back pain trial By Investing.com - Investing.com South Africa
Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy - The Manila Times
Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC - The Manila Times
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - The Manila Times
Retell AI, Fastest-Growing AI Voice Agent Platform, Launches First Automated QA Solution to Accelerate Enterprise Adoption of Voice AI - The Manila Times
New cell therapy for chronic back pain reaches key milestone in clinical test - Stock Titan
Kretto Syscon Limited Recovery Linked to Earnings SurpriseStock Watchlist Updates & High Return Market Tips - Bollywood Helpline
Shiv Texchem Limited Stock Lags Behind Sector BenchmarksTrade Execution Strategies & Free Unlock Stock Analysis - Bollywood Helpline
Resistance Break Could Fuel Diligent Media Corporation Limited RallyCup and Handle Formations & Budget Friendly Portfolio Growth - Bollywood Helpline
Market Moves: Will Creative Medical Technology Holdings Inc. stock deliver better than expected guidance2025 Major Catalysts & AI Powered Trade Plan Recommendations - moha.gov.vn
Creative Medical Technology (NASDAQ:CELZ) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Is Creative Medical Technology Holdings Inc. stock a safe buy before earnings - Newser
WHO approves olastrocel as international name for CELZ-201 therapy By Investing.com - Investing.com Nigeria
Creative Medical Technology Holdings Announces World Health Organization Approval of "Olastrocel" as Inn for Lead Allogeneic Cell Therapy Celz-201 - marketscreener.com
Creative Medical (CELZ) Gains WHO Approval for Key Therapy Compo - GuruFocus
WHO approves olastrocel as international name for CELZ-201 therapy - Investing.com
Creative Medical Technology Holdings announces World Health Organization approval of "Olastrocel" - marketscreener.com
Creative Medical Technology Holdings Announces World Health Organization Approval of 'olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - The Manila Times
Creative Medical (NASDAQ: CELZ) gets WHO INN 'olastrocel' for CELZ-201 cell therapy - Stock Titan
Creative Planning Acquires 4,480 Shares of Teleflex Incorporated $TFX - MarketBeat
SS&C Technologies Holdings, Inc. $SSNC Shares Purchased by Creative Planning - MarketBeat
Creative Planning Boosts Holdings in Charles River Laboratories International, Inc. $CRL - Defense World
Creative Planning Has $1.82 Million Stake in Akamai Technologies, Inc. $AKAM - MarketBeat
Creative Planning Has $1.90 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat
Creative Medical Technology Holdings Inc (CELZ) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Setenews
Creative Planning Purchases 141 Shares of Medpace Holdings, Inc. $MEDP - Defense World
Analyst Calls: Will Creative Medical Technology Holdings Inc. stock deliver better than expected guidance - BỘ NỘI VỤ
TransMedics Group, Inc. $TMDX Shares Acquired by Creative Planning - MarketBeat
Creative Planning Purchases 9,537 Shares of iShares U.S. Medical Devices ETF $IHI - Defense World
Creative Planning Grows Position in Align Technology, Inc. $ALGN - Defense World
Creative Planning Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Creative Planning Has $4.29 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
[S-3] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Shelf Registration Statement | CELZ SEC FilingForm S-3 - Stock Titan
Seagate Technology Holdings PLC $STX Shares Bought by Creative Planning - MarketBeat
Can Creative Medical Technology Holdings Inc. stock attract ESG capital inflowsWeekly Gains Report & AI Driven Price Forecasts - newser.com
Trend analysis for Creative Medical Technology Holdings Inc. this week - newser.com
Full technical analysis of Creative Medical Technology Holdings Inc. stockTrade Volume Report & Daily Oversold Stock Bounce Ideas - newser.com
Is Creative Medical Technology Holdings Inc. stock cheap compared to fundamentals - newser.com
Is Creative Medical Technology Holdings Inc. stock affected by interest rate hikesJuly 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
Why Creative Medical Technology Holdings Inc. stock is trending among retail tradersRate Cut & Weekly Market Pulse Updates - newser.com
Mergers & Acquisitions Tracker - Plastics News
How Creative Medical Technology Holdings Inc. stock performs in weak economy2025 Price Momentum & Consistent Income Trade Ideas - newser.com
CELZ (Creative Medical Technology Holdings) Shares Outstanding (EOP) : 2.58 Mil (As of Sep. 2025) - GuruFocus
Creative Planning Increases Stake in Stryker Corporation $SYK - MarketBeat
How Creative Medical Technology Holdings Inc. stock reacts to job market data2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Sentiment analysis tools applied to Creative Medical Technology Holdings Inc.2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Creative Medical Technology Holdings approves bonuses for CEO and CFO By Investing.com - Investing.com Canada
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Creative Medical Technology Holdings Inc Stock (CELZ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Finger Michael H. | Director |
Feb 18 '25 |
Sale |
5.00 |
750 |
3,750 |
1,101 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):